Differential regulation of dopamine receptor subtypes by novel atypical antipsychotic drugs

被引：0
|
作者：
Tarazi, FI
Zhang, K
Baldessarini, RJ
机构：
[1] Harvard Univ, Sch Med, Program Neurosci, Belmont, MA 02478 USA
[2] McLean Hosp, Mailman Res Ctr, Belmont, MA 02478 USA
[3] Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02478 USA
来源：
JOURNAL OF NEUROCHEMISTRY | 2001年 / 78卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [1] Dopamine receptor subtypes: Differential regulation after 8 months treatment with antipsychotic drugs
    Florijn, WJ
    Tarazi, FI
    Creese, I
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 280 (02): : 561 - 569
  • [2] NOVEL DOPAMINE-RECEPTOR SUBTYPES AS TARGETS FOR ANTIPSYCHOTIC-DRUGS
    SOKOLOFF, P
    DIAZ, J
    LEVESQUE, D
    PILON, C
    DIMITRIADOU, V
    GRIFFON, N
    LAMMERS, CH
    MARTRES, MP
    SCHWARTZ, JC
    DIVERSITY OF INTERACTING RECEPTORS, 1995, 757 : 278 - 292
  • [3] Dopamine receptor subtypes: Differential regulation following chronic antipsychotic drug treatment
    Tarazi, FI
    Florijn, W
    Creese, I
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 : S58 - S58
  • [4] The atypical antipsychotic olanzapine is an antagonist at dopamine, serotonin and muscarinic receptor subtypes
    Bymaster, FP
    Nelson, DL
    DeLapp, NW
    Lucaites, VL
    Wainscott, DB
    Falcone, JF
    Eckols, K
    Foreman, MM
    Calligaro, DO
    SCHIZOPHRENIA RESEARCH, 1996, 18 (2-3) : VIA2 - VIA2
  • [5] DIFFERENTIAL REGULATION OF DOPAMINE-RECEPTOR SUBTYPES FOLLOWING CHRONIC TYPICAL AND ATYPICAL NEUROLEPTIC TREATMENT
    TARAZ, FI
    FLORIJN, WJ
    CREESE, I
    JOURNAL OF NEUROCHEMISTRY, 1995, 65 : S12 - S12
  • [6] Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment
    Tarazi, FI
    Florijn, WJ
    Creese, I
    NEUROSCIENCE, 1997, 78 (04) : 985 - 996
  • [7] Differential actions of typical and atypical antipsychotic drugs on dopamine release in the core and shell of the nucleus accumbens
    Marcus, MM
    Nomikos, GG
    Svensson, TH
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1996, 6 (01) : 29 - 38
  • [8] Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes
    Lawler, CP
    Prioleau, C
    Lewis, MM
    Mak, C
    Jiang, D
    Schetz, JA
    Gonzalez, AM
    Sibley, DR
    Mailman, RB
    NEUROPSYCHOPHARMACOLOGY, 1999, 20 (06) : 612 - 627
  • [9] Interactions of the Novel Antipsychotic Aripiprazole (OPC-14597) with Dopamine and Serotonin Receptor Subtypes
    Cindy P Lawler
    Cassandra Prioleau
    Mechelle M Lewis
    Chun Mak
    Dong Jiang
    John A Schetz
    Antonio M Gonzalez
    David R Sibley
    Richard B Mailman
    Neuropsychopharmacology, 1999, 20 : 612 - 627
  • [10] Effects on serotonin and dopamine receptors in the mechanism of atypical antipsychotic drugs
    Meltzer, HY
    Kessler, R
    Li, Z
    Chung, Y
    Ichikawa, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S164 - S165
12345